Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy

Abstract Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. W...

Full description

Bibliographic Details
Main Authors: S. M. Nashir Udden, GuemHee Baek, Kamal Pandey, Chantal Vidal, Yulun Liu, Asal S. Rahimi, D. Nathan Kim, Chika R. Nwachukwu, Ram S. Mani, Prasanna G. Alluri
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-023-00348-1
_version_ 1797641434325581824
author S. M. Nashir Udden
GuemHee Baek
Kamal Pandey
Chantal Vidal
Yulun Liu
Asal S. Rahimi
D. Nathan Kim
Chika R. Nwachukwu
Ram S. Mani
Prasanna G. Alluri
author_facet S. M. Nashir Udden
GuemHee Baek
Kamal Pandey
Chantal Vidal
Yulun Liu
Asal S. Rahimi
D. Nathan Kim
Chika R. Nwachukwu
Ram S. Mani
Prasanna G. Alluri
author_sort S. M. Nashir Udden
collection DOAJ
description Abstract Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.
first_indexed 2024-03-11T13:45:36Z
format Article
id doaj.art-c99af9910d324a5f889bbd6bf2d4236c
institution Directory Open Access Journal
issn 2397-768X
language English
last_indexed 2024-03-11T13:45:36Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series npj Precision Oncology
spelling doaj.art-c99af9910d324a5f889bbd6bf2d4236c2023-11-02T10:37:50ZengNature Portfolionpj Precision Oncology2397-768X2023-01-01711810.1038/s41698-023-00348-1Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapyS. M. Nashir Udden0GuemHee Baek1Kamal Pandey2Chantal Vidal3Yulun Liu4Asal S. Rahimi5D. Nathan Kim6Chika R. Nwachukwu7Ram S. Mani8Prasanna G. Alluri9Department of Radiation Oncology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterHarold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterDepartment of Pathology, UT Southwestern Medical CenterDepartment of Radiation Oncology, UT Southwestern Medical CenterAbstract Targeted therapies, such as endocrine therapies (ET), can exert selective pressure on cancer cells and promote adaptations that confer treatment resistance. In this study, we show that ET resistance in breast cancer drives radiation resistance through reprogramming of DNA repair pathways. We also show that pharmacological bromodomain and extraterminal domain inhibition reverses pathological DNA repair reprogramming in ET-resistant breast tumors and overcomes resistance to radiation therapy.https://doi.org/10.1038/s41698-023-00348-1
spellingShingle S. M. Nashir Udden
GuemHee Baek
Kamal Pandey
Chantal Vidal
Yulun Liu
Asal S. Rahimi
D. Nathan Kim
Chika R. Nwachukwu
Ram S. Mani
Prasanna G. Alluri
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
npj Precision Oncology
title Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
title_full Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
title_fullStr Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
title_full_unstemmed Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
title_short Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy
title_sort towards precision radiation oncology endocrine therapy response as a biomarker for personalization of breast radiotherapy
url https://doi.org/10.1038/s41698-023-00348-1
work_keys_str_mv AT smnashirudden towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT guemheebaek towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT kamalpandey towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT chantalvidal towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT yulunliu towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT asalsrahimi towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT dnathankim towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT chikarnwachukwu towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT ramsmani towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy
AT prasannagalluri towardsprecisionradiationoncologyendocrinetherapyresponseasabiomarkerforpersonalizationofbreastradiotherapy